Cholestasis
Return to Digestive System Disorders Menu
When there is a disorder, cholestasis means bile secretory failure, it could be at the level of the canaliculus, the small bile ducts or the larger ones. The net effect is reduced biliary secretion into the intestine.
The decrease in bile flow can be due to impaired secretion by hepatocytes or to obstruction of bile flow through intra-or extrahepatic bile ducts. Therefore, the clinical definition of cholestasis is any condition in which substances normally excreted into bile are retained.
When that happens, components of the bile gain access to the blood (we don’t know how it happens). The plasma level of these substances that would normally be excreted, goes up. Not the bile pigment. People become jaundiced because the bile pigment isn’t recirculated, it’s a waste product from the degradation of heme. Once it’s in the intestine, its excreted and there is no enterohepatic circulation. There’s about a ten-fold capacity to secrete the bile pigment than is used (a safety valve). So you have to have substantial liver disease in order for people to become jaundiced and that's a bad prognostic sign.
The serum concentrations of conjugated bilirubin and bile salts are the most commonly measured.
Not all substances normally excreted into bile are retained to the same extent in various cholestatic disorders. In some conditions, serum bile salts may be markedly elevated while bilirubin is only modestly elevated and vice versa. However, demonstrable retention of several substances is needed to establish a diagnosis of cholestasis. Only in rare disorders of bilirubin metabolism (eg, Dubin-Johnson syndrome, Rotor syndrome) does an isolated increase in the serum concentration of conjugated bilirubin appear, so increased serum conjugated bilirubin indicates cholestasis. The histopathologic definition of cholestasis is the appearance of bile within the elements of the liver, usually associated with secondary cell injury.
Cholestasis can be seen in Primary biliary cirrhosis. A symptom can be skin itching, darkening and thickening of skin. Elevated bile acids in the skin and irritation of nerve endings can produce itching, another explanation is over stimulation of opioid receptors in which case naltrexone can be helpful.
Wikipedia:
The signs and symptoms of cholestasis vary according to the cause. In case of sudden onset, the disease is likely to be acute, while the gradual appearance of symptoms suggests chronic pathology. In many cases, patients may experience pain in the abdominal area. Localization of pain to the upper right quadrant can be indicative of cholecystitis or choledocholithiasis, which can progress to cholestasis.
Pruritus or itching is often present in many patients with cholestasis. Patients may present with visible scratch marks as a result of scratching. Pruritus is often misdiagnosed as a dermatological condition, especially in patients that do not have jaundice as an accompanying symptom. In a typical day, pruritus worsens as the day progresses, particularly during the evening time. Overnight, pruritus dramatically improves. This cycle can be attributed to an increase in the concentration of biliary elements during the day due to food consumption, and a decline at night. Pruritus is mostly localized to the limbs, but can also be more generalized.
Many patients may experience jaundice as a result of cholestasis.[6] This is usually evident after physical examination as yellow pigment deposits on the skin, in the oral mucosa, or conjunctiva.[1][7] Jaundice is an uncommon occurrence in intrahepatic (metabolic) cholestasis, but is common in obstructive cholestasis. The majority of patients with chronic cholestasis also experience fatigue.[8] This is likely a result of defects in the corticotrophin hormone axis or other abnormalities with neurotransmission.[1] Some patients may also have xanthomas, which are fat deposits that accumulate below the skin.[9] These usually appear waxy and yellow, predominantly around the eyes and joints.[10] This condition results from an accumulation of lipids within the blood.[11] If gallstones prevent bile flowing from the pancreas to the small intestine, it can lead to gallstone pancreatitis. Physical symptoms include nausea, vomiting, and abdominal pain.
Articles/Studies
- Lycopene** might have protective effects on acute cholestasis.
- Paeonia lactiflora** regulates the NF-κB-NLRP3 inflammasome pathway to alleviate cholestasis.
- Boldine** attenuates cholestasis associated with nonalcoholic fatty liver disease in hereditary hypertriglyceridemic rats fed by high-sucrose diet.
- Psyllium fiber** has a unique effect on cholesterol plasma removal and excretion.
- R-alpha-lipoic acid** inhibits glucose production and stimulates bile flow in the rat liver.
- Red yeast** increases excretion of bile acids in hamsters.
- Silymarin** increases hepatoprotective biliary bile sale secretion in the rat.
- Silymarin**, a compound found within milk thistle seed, prevents estrogen-induced cholestasis in the rats.
- The present study demonstrated the synergistic effects of **RGHP** in ANIT-induced cholestatic rats at pharmacodynamic and pharmacokinetic levels.
- The results of this study suggest that **magnesium sulfate** treatment may be beneficial in cholestasis induced hepatotoxicity.
- Thymoquinone** can be used as a liver protectant in patients with cholestasis.
- Curcumin** reduces the programmed cell death associated with toxic bile acids in liver injury during cholestasis.
- Peppermint oil** stimulates bile fluid secretion and thus has a choleretic effect.
- Crocin** may have improvement effects on cholestasis-induced neuroinflammation in the rat's striatum.